Electromed, Inc. (NYSE:ELMD) Q2 2024 Earnings Conference Call February 13, 2024 5:00 PM ET Company Participants Mike Cavanaugh - Investor Relations, ICR Westwicke Jim Cunniff - President & Chief Executive Officer Brad Nagel - Chief Financial Officer Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Greetings and welcome to the Electromed Second Quarter Fiscal 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to ...

For the transition period from to . Commission File No.: 001-34839 Electromed, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact Name of Registrant as Specified in its Charter) Minnesota 41-1732920 (State or other jurisdiction ...

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 second quarter ended December 31, 2023, on February 13, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by ...

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB). SmartVest® Airway Clearance System, which is designed for High Frequency Chest Wall Oscillation (“HFCWO”) therapy, a clinically proven therapy that helps clear the lungs of excess secretions, thereby reducing the risk of respiratory infections and h ...

Electromed, Inc. (NYSE:ELMD) Q1 2024 Results Conference Call November 7, 2023 5:00 PM ET Company Participants Mike Cavanaugh - IR, ICR Westwicke Jim Cunniff - President and CEO Brad Nagel - CFO Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Good day, and welcome to the Electromed First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note today’s event is being recorded. I would now like to turn the conference over to Mike Cavanaugh with ICR Westwicke. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 41-1732920 (State or other jurisdiction ...

Electromed, Inc. (NYSE:ELMD) Q4 2023 Earnings Call Transcript August 22, 2023 5:00 PM ET Company Participants Mike Cavanaugh - IR Jim Cunniff - President and CEO Brad Nagel - CFO Conference Call Participants Brooks O'Neil - Lake Street Operator Greetings, and welcome to Electromed's Fourth Quarter Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] It is now my pleasure to introdu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From ________ to ________. Commission File number 001-34839 Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of (IRS Emp ...

Electromed, Inc. (NYSE:ELMD) Q3 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Mike Cavanaugh - Investor Relations Kathleen Skarvan - President and Chief Executive Officer Brad Nagel - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Welcome to the Electromed Third Quarter Fiscal 2023 Financial Results Conference Call [Operator Instructions]. I will now turn the call over to your host, Mike Cavanaugh, Investor Relations. Mr. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . (Address of principal executive offices) (Zip Code) (952) 758-9299 (Registrant's telephone number, including area code) Securities registered pursuant to Se ...